ClinicalTrials.gg
Enrolling by invitationNCT06972979Updated Oct 23, 2026

Investigation of a Patient Support Intervention for Statin Medication Adherence

An interventional study of Text Message Gamification and Remote Support in Medication Adherence, sponsored by Ascension Health. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Ascension Health · Not applicable, Interventional, and Health services research

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
2,200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 463 studies in Medication Adherence with a site in United States — 59 open to participants now, 74 under way, 1 of them phase 3. Medication Adherence · United States.

Planned enrollment
15th of 422
2,200 · median 96
Started
2026
with 18 others
No phase
368 of 463
53 open now
Primary completion
2027-03
later than 23 of 73 live
Registered
432nd of 463
by date

Among the 463 studies in Medication Adherence with a site in United States, this one is the 15th largest by planned enrollment of the 422 interventional ones that give a count, is one of 19 that started in 2026, is one of 368 with no phase, reaches primary completion later than 23 of the 73 other live ones, and was the 432nd registered.

Medication Adherence

943 studies on the registry are indexed under Medication Adherence; 162 are open to participants now.

Browse Medication Adherence studies →

Open to participants now

59 of the 463 studies in Medication Adherence with a site in United States are open now. Recruiting first, the newest first:

54 more — sign in →

All 59 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 81 Medication Adherence studies recruiting now, 52 (64%) set no upper age limit and 21 (26%) stop at 75 or younger; 15 take children under 18; 12 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 463 studies in Medication Adherence with a site in United States, or all of them as a file.
02

Study summary

Statins have been demonstrated to significantly reduce the risk of cardiovascular disease, but adherence to these medications is suboptimal. Improving adherence can be challenging because it is multifactorial and behaviors often occur within the everyday lives of patients and are less addressable during a visit with a clinician. In this study, the investigators will conduct a randomized trial to evaluate a behaviorally-designed gamification intervention with remote nursing support to improve statin adherence.

Read the detailed description

Improving medication adherence can be challenging because behaviors occur within the everyday lives of patients. Therefore, intermittent visit-based adherence interventions or refill reminders have had limited impact. Remote Patient Monitoring (RPM) has been demonstrated in other settings to improve daily health behaviors when combined with automated outreach and a behavioral change strategy, such as gamification. These approaches have been demonstrated to be effective for other daily behaviors such as increasing physical activity levels among a wide range of patient populations including those at elevated risk for major cardiovascular events. MedTrack is a text message-based remote patient monitoring program with several key components: (I) medication check-ins with the ability to set the time(s) for daily medication reminders, (II) a gamification experience to drive behavior change, (III) ability to identify a support partner who receives weekly updates on the patient's game status; (IV) access to an RN team for clinical questions and care coordination, and (V) patients' providers can see real-time progress within an electronic health record (EHR) integrated application.

03

Conditions studied

  • Medication Adherence

Browse trials for

Keywords

  • Gamification
  • Remote Support
  • Statin
  • Adherence
  • Primary Care
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults, age 18 and older
  • Have a phone or email on file to receive outreach to participate in the study
  • Have a primary care provider (PCP) employed by Ascension.
  • Prescribed a statin medication and had filled two statin prescriptions in the previous 12 months (one in the prior 6 months and another in the previous 6 to 12 months)
  • PDC \<80% in the prior 12 months
  • Have consented for electronic communications with Ascension

Exclusion criteria

Exclusion Criteria:

  • Patients will be excluded if they do not meet our inclusion criteria.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
2,200 participants (estimated)

Study arms

  • No intervention
    Usual Care

    Participants in the usual care arm will have consented for participation and will be informed they are on a waiting list for approximately 6-12 months. During that time they will receive no additional interventions beyond usual care and not be be invited again to enroll in the MedTrack program.

  • Experimental
    Text Message Group

    Participants in the intervention arm will have consented for participation in the MedTrack program and will receive the text message intervention and remote support within 1-2 weeks of enrolling.

    Behavioral: Text Message Gamification and Remote Support

Interventions

  • BehavioralText Message Gamification and Remote Support

    Participants in the intervention arm consists of several components: (I) medication check-ins with the ability to set the time(s) for daily medication reminders, (II) a gamification experience to drive behavior change, (III) ability to identify a support partner who receives weekly updates on the patient's game status; (IV) access to an RN team for clinical questions and care coordination, and (V) patients' providers can see real-time progress within an electronic health record (EHR) integrated application.

06

What researchers measure

Primary outcomes

  1. Statin adherence, population average

    Statin adherence, measured using the proportion of days covered (PDC), during the 6-month intervention period

    Time frame: 6-months after enrollment

Secondary outcomes

  1. Statin adherence, proportion of population with PDC>=80%

    Proportion of patients with statin PDC adherence greater than or equal to 80% during the 6-month intervention period

    Time frame: 6-months after enrollment

07

Study locations

1 site
  • Ascension Health
    St Louis, Missouri 63134, United States
08

References and documents

Individual participant data

Plan to share: No — The study has patient information that the investigators are not approved to share.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Mar 2027, 11 months after the start.

Of 447 interventional studies with no phase under Medication Adherence, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 41. This study's planned 11 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
May 7, 2025
First posted
May 15, 2025
StartActual
Apr 20, 2026
Primary completionEst.
Mar 2027
CompletionEst.
May 2027
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date and responsible party
1 update, last Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    Minor edits only
    + 2 other changes: verification date and responsible party

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06972979
Lead sponsor
Ascension Health
Responsible party
Krisda Chaiyachati (AVP, Clinical Transformation, Ascension Health) — Principal investigator
First posted
May 15, 2025
Start date
Apr 20, 2026
Primary completion
Mar 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Oct 23, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion